Authors
Latest:
Triplet therapy including darolutamide should be standard of care in mCSPC, data indicateResults of the ARASENS trial (NCT02799602) demonstrated that darolutamide plus ADT and docetaxel prolonged overall survival regardless of disease volume or risk.
Latest:
Real-world data point to underutilization of germline, somatic testing in mCRPC"Certainly germline and somatic is recommended for all mCRPC patients to detect HR gene mutations, and consider options for PARP inhibitors,” says Neal Shore, MD, FACS.
Latest:
Chronic orchialgia: How to diagnose and treat the challenging conditionIn this interview, Parviz K. Kavoussi, MD, discusses his diagnostic work-up for patients who present with chronic testicular pain and describes conservative and surgical management approaches for the condition.
Latest:
Expert explains why automation is key to prior authorization reformAutomating prior authorization is an investment that every health care organization should consider. As the industry grapples with rapid regulatory shifts and acute staff shortages, a tailored automation strategy is key to enhancing patient care and improving operational efficiency.
Latest:
William Furuyama, MD, on community factors’ influence on urinary incontinence“Having a broader understanding of why someone might be experiencing the disease process or symptoms that they're coming in with is really meaningful and helpful, both to patients and to physicians,” says William Furuyama, MD.
Latest:
How data and technology facilitate health equity and boost the overall patient experience"Digital engagement technology, which can be seamlessly integrated into a health system or hospital's existing processes," writes Chelsea King Arthur.
Latest:
Enhancing Patient-Centric Management in OAB in 2024 and BeyondPanelists conclude their discussion by reflecting on key learnings and sharing advice for patient-centric management in overactive bladder (OAB) treatment, specifically focusing on effective communication and overlooked aspects of patient care. They offer guidance to other providers on enhancing patient experiences, particularly with procedures like Botox. The episode wraps up with each expert sharing their final thoughts and anticipations for advancements in OAB treatment in 2024, highlighting their commitment to addressing patient needs in this evolving field.
Latest:
Juan Andino, MD, highlights SUO session on telehealth in urology“Without Congressional action, all the progress that has been made—the new normal, so to speak—that patients, physicians, and providers alike have become used to, is at risk of potentially going back to pre-pandemic, 2019 levels,” says Juan J. Andino, MD, MBA.
Latest:
Vikram Narayan, MD, on the importance of tailoring patient communication“The key take home message of that study was that having assumptions about basic medical terminology that we think are simple may actually leave patients confused,” says Vikram M. Narayan, MD.
Latest:
How urologists can discuss testosterone labeling changes with patients"I hope that these new guidelines and the removal of the black box warning on testosterone therapy will help more physicians feel comfortable providing testosterone therapy to men," says Helen L. Bernie, DO, MPH.
Latest:
Is a medical scribe right for your practice?“Regardless of the size of the practice, medical scribes are a valuable resource for health care providers, helping to streamline workflow and coordinate patient care,” writes Brian Hudson.
Latest:
Experts discuss review of the microbiome and bladder cancer"My biggest hope for people reading this review is to understand that there are some golden opportunities for research," says Laura Bukavina, MD, MPH, MSc.
Latest:
Diagnostic stewardship for urinary tract infection: A snapshot of the expert guidanceUrinary tract infections (UTIs) are among the most common human infections. But the urine culture, the cornerstone for laboratory diagnosis of UTI, is imperfect.
Latest:
Combo of cabozantinib and pembrolizumab shows promise in frontline urothelial carcinomaResults from the phase 2 PemCab trial showed that the first-line combination elicited promising antitumor activity with tolerable toxicity in patients with advanced urothelial carcinoma, including those who were cisplatin ineligible.
Latest:
Mark Edney, MD, highlights pending telehealth legislation"The relaxation of the restrictions that started during COVID are critically important for continued access," says Mark T. Edney, MD.
Latest:
FDA grants Regenerative Medicine Advanced Therapy designation to ALLO-316 for RCCThe RMAT designation is supported by interim data from the ongoing phase 1 TRAVERSE trial.
Latest:
Checkpoint Inhibitors for Treatment of NMIBCExperts share their initial impressions of the available data on immunotherapies, including PD-L1 inhibitors durvalumab and sasanlimab, being evaluated in bacille Calmette-Guérin (BCG)–unresponsive patients with non–muscle-invasive bladder cancer (NMIBC).
Latest:
Expert highlights program addressing disparities in prostate cancer careIn this interview, Mary-Ellen Taplin, MD, discusses disparities in prostate cancer care and a unique initiative aiming to alleviate those disparities.
Latest:
Scott Tagawa, MD, on the mechanism of action for 177Lu-TLX591 in mCRPC“If there's enough radiation, then the cells can't repair themselves and die because of the radiation,” says Scott T. Tagawa, MD, MS, FACP, FASCO.
Latest:
Data support use of 18F-PSMA-1007 PET/CT in prostate cancer“These findings support the use of 18F-PSMA-1007 PET/CT in the preoperative workflow of intermediate-and high-risk tumors,” said Nikhile Mookerji, MD.
Latest:
How to assemble a Thompson Retractor for midline transabdominal retroperitoneal surgeryThe patient presented with a large right renal mass who elected for right radical nephrectomy with possible inferior vena cava.
Latest:
Amar Kishan, MD, highlights ongoing research on reducing toxicity in SBRT"For the MIRAGE trial specifically, we're going to continue following patients and we'll look at [data at] 5 years as well," says Amar U. Kishan, MD.
Latest:
Diet and interstitial cystitis: A urologist’s view"There are some very strict IC diets that have been published, and I've had a handful of patients who have really found them helpful," says J. Quentin Clemens, MD, MSCI.
Latest:
Tips for successfully mentoring other physiciansHere are some helpful hints for launching your physician mentor-mentee relationship.
Latest:
Sima Porten, MD, discusses the need to educate on the firefighter-bladder cancer link"They are risking their own lives for their job, so it's the part of the whole community to do our best to try to keep them safe," says Sima P. Porten, MD, MPH.
Latest:
Episode 3 Video: Managing Overactive Bladder: From Dual Diagnoses to Geriatric ChallengesWayne Kuang, MD; and Matt T. Rosenberg, MD, discuss how overactive bladder presents with distinct pathophysiological mechanisms between genders, requires different diagnostic approaches when distinguishing from benign prostatic hyperplasia in men, impacts quality of life in older adults, benefits from early primary care intervention, and necessitates improved patient advocacy and educational initiatives for optimal management outcomes.
Latest:
Episode 2 Video: Identifying Patients with Intermediate Risk in NMIBCPanelists explore challenges in identification of intermediate risk patients and emphasize importance of risk stratification to improve outcomes in regards to NMIBC.
Latest:
Dr. Lara reviews the evolving systemic therapy paradigm in renal cell carcinoma“The question of who is a candidate for active surveillance is hard to answer because this is a bedside, gut decision," says Primo Nery Lara, Jr, MD.
Latest:
Chad Reichard, MD, on the Expanded Access Program for recombinant BCG"This certainly does feel like the beginning of the light at the end of the tunnel coming out of the BCG shortage," says Chad A. Reichard, MD.
Latest:
The importance of federal funding in cancer research: A call to action"We must lobby to maintain our current funding levels and push for increased support to continue driving progress in cancer care," says Michael S. Cookson, MD, MMHC, FACS.
